CSEIX
Price
$17.09
Change
+$0.15 (+0.89%)
Updated
Nov 7 closing price
PAREX
Price
$13.36
Change
+$0.13 (+0.98%)
Updated
Nov 7 closing price
Ad is loading...

CSEIX vs PAREX

Header iconCSEIX vs PAREX Comparison
Open Charts CSEIX vs PAREXBanner chart's image
Cohen & Steers Real Estate Securities A
Price$17.09
Change+$0.15 (+0.89%)
VolumeN/A
CapitalizationN/A
T. Rowe Price Real Estate Advisor
Price$13.36
Change+$0.13 (+0.98%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CSEIX vs PAREX Comparison Chart
Loading...
VS
CSEIX vs. PAREX commentary
Nov 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSEIX is a Buy and PAREX is a Buy.

FUNDAMENTALS
Fundamentals
CSEIX pays higher dividends than PAREX: CSEIX (2.92) vs PAREX (2.17). CSEIX was incepted earlier than PAREX: CSEIX (27 years) vs PAREX (20 years). CSEIX is a more actively managed with annual turnover of: 41.00 vs. PAREX (9.60). CSEIX has a lower initial minimum investment than PAREX: CSEIX (0) vs PAREX (2500). CSEIX annual gain was more profitable for investors over the last year : 30.06 vs. PAREX (15.26). CSEIX return over 5 years is better than : 20.57 vs. PAREX (-50.94).
CSEIXPAREXCSEIX / PAREX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence27 years20 years-
Gain YTD12.5947.643165%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets8.2BN/A-
Annual Yield % from dividends2.922.17135%
Returns for 1 year30.0615.26197%
Returns for 3 years-7.51-36.6620%
Returns for 5 years20.57-50.94-40%
Returns for 10 years37.39-38.91-96%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BOF1.660.10
+6.41%
BranchOut Food
EXFY1.980.06
+3.12%
Expensify
STOK13.270.02
+0.15%
Stoke Therapeutics
CPB45.12-1.12
-2.42%
Campbell Soup Company
IART25.51-1.19
-4.46%
Integra LifeSciences Holdings Corp